NCT03843580View on ClinicalTrials.gov

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

February 10, 2021

Study Completion Date

February 10, 2022

Conditions
Apnea, PostanestheticDesaturation of BloodApneaAnesthesiaLarynx DiseasePharynx; Anomaly
Interventions
DEVICE

optiflow

we use Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (thrive-optiflow) during general anesthesia for suspension laryngoscopy

Trial Locations (2)

14000

CaenUH, Caen

Centre François Baclesse, Caen

All Listed Sponsors
collaborator

Centre Francois Baclesse

OTHER

lead

University Hospital, Caen

OTHER

NCT03843580 - Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo) | Biotech Hunter | Biotech Hunter